Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness.

Market Analysis and Insights: Global Intravenous (IV) Ibuprofen Market
The global Intravenous (IV) Ibuprofen market was valued at US$ 8103.3 in 2020 and will reach US$ 15400 million by the end of 2027, growing at a CAGR of 11.3% during 2022-2027.

Global Intravenous (IV) Ibuprofen Scope and Market Size
The global Intravenous (IV) Ibuprofen market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous (IV) Ibuprofen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
100 mg Dose
200 mg Dose
400 mg Dose
800 mg Dose

Segment by Application
Pain
Fever
Inflammation

The Intravenous (IV) Ibuprofen market is analysed and market size information is provided by regions (countries). Segment by Application, the Intravenous (IV) Ibuprofen market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Cumberland Pharmaceuticals
Alveda Pharmaceuticals
CSL Limited
Sandor Medicaids
PT. Soho Industri Pharmasi
Germin MED
Grifols
Gloria Pharmaceuticals
Al Nabeel International
Laboratorios Valmorca